Stock screener

VRTX

Conviction 59HealthcareScan · Thu, Jun 25, 2026
VRTX$479.74+0.96%
ResistanceSupportVol 14Insider sellCongress buyCongress sell
63 bars
2
Vol MA14 1.56M
Mar 26Apr 14May 1May 19Jun 8Jun 25
WSB mentions · 24h changelatest +100.00%· 2 mentions
Mar 26Apr 14May 1May 19Jun 8Jun 25
VERTEX PHARMACEUTICALS INC / MAPHARMACEUTICAL PREPARATIONSwww.vrtx.com
Price479.74
Change+0.96%
Gap+0.20%
Rel volume1.95×
Avg volume1.52M
Avg $ vol685.75M
SMA 20449.74
SMA 50440.52
SMA 200441.16
Price vs 50+8.90%
Price vs 200+8.75%
MA stackmixed
50/200 cross
Supertrendup · 444.43
RSI (14)69
MACD hist3.63
MACD cross
Stoch %K / %D87 / 90
ADX (14)19
+DI / −DI30 / 11
RSI divergence
MACD divergence
ATR %+2.46%
ADR %2.49%
52w high499.17
52w low366.54
From 52w high-3.89%
Above 52w low+30.88%
New 52w highNo
SqueezeOff
Bollinger width12.37%
%B1.04
Donchian pos89.84%
Donchian high486.50
Donchian low420.01
AVWAP (52w high)447.76
vs AVWAP high+7.14%
AVWAP (52w low)436.04
vs AVWAP low+10.02%
OBV trendUp
Chaikin MF (20)0.11
Today vs 20d1.95×
Avg vol (14d)1.56M
Avg vol (20d)1.52M
Avg $ vol (20d)685.75M
Market cap121.76B
RS 3m (vs SPY)-6.33%
RS 6m (vs SPY)-3.57%
RS line new highNo
Trend template6/8
Technical rank72.1
1 week+4.52%
1 month+10.05%
3 months+5.44%
6 months+4.22%
1 year+6.54%
YTD+6.11%
P/E30.80
P/B6.29
P/S10.15
P/FCF38.12
EPS15.32
Div yield
ROE20.42%
ROA14.93%
Debt/Eq0.01
Current3.02
EV/EBITDA26.55
Gross margin
Net margin32.94%
Rev growth8.90%
EPS growth838.09%
Price target562.95
Target upside17.34%
Analyst ratingBuy
Institutional102.49%
Ent. value116.37B
Revenue2.99B
Net income1.03B
Gross profit
Free cash flow3.19B
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out253.81M
Employees6.4K
ListedWed, Jul 31, 1991
Free float253.88M
Float %99.8%
Short interest4.49M
Days to cover3.2d
Short volume66.2%
Squeeze score51 / 100
Next earningsMon, Aug 3, 2026 (39d)
EPS forecast$4.25 · 6 est
Last EPS vs est$3.95 vs $3.69
Last surprise+7.0% beat
Setup gradeC
Conviction59 / 100
Pattern quality
Tech rank72.1 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction
Pattern family
Resistance454.92
Support416.14
Days since event
Candle confirm
News sentiment

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in VRTX · 9 recent

All disclosures →
MemberSideAmount
David J. Taylor
David J. Taylor
house · R · OH · traded 2025-08-07
Buy$1K–$15K
Lisa McClain
Lisa McClain
house · R · MI · traded 2024-12-11
Buy$1K–$15K
Lisa McClain
Lisa McClain
house · R · MI · traded 2025-06-11
Sell$1K–$15K
Lisa McClain
Lisa McClain
house · R · MI · traded 2025-06-10
Sell$1K–$15K
Jefferson Shreve
Jefferson Shreve
house · R · IN · traded 2025-05-12
Sell$15K–$50K
Byron Donalds
Byron Donalds
house · R · FL · traded 2025-03-20
Sell$1K–$15K
Jefferson Shreve
Jefferson Shreve
house · R · IN · traded 2025-03-13
Buy$15K–$50K
Jefferson Shreve
Jefferson Shreve
house · R · IN · traded 2025-02-24
Buy$15K–$50K
Thomas H Tuberville
Thomas H Tuberville
senate · traded 2024-05-03
Sell$1K–$15K

Insider activity

SEC Form 4 transactions in VRTX · 1 buy · 9 sells

InsiderSideShares
Bozic Carmen
EVP and CMO · Common Stock · 2026-06-15
Sell4.06K
Bozic Carmen
EVP and CMO · Common Stock · 2026-06-05
Sell1.75K
Liu Joy
EVP and Chief Legal Officer · Common Stock · 2026-06-01
Sell828
Bozic Carmen
EVP and CMO · Common Stock · 2026-05-29
Sell1.97K
Bunnage Mark E.
EVP, Chief Scientific Officer · Common Stock · 2026-05-15
Sell33
Bozic Carmen
EVP and CMO · Common Stock · 2026-05-15
Sell1.35K
Bozic Carmen
EVP and CMO · Common Stock · 2026-05-12
Sell6.99K
Bhatia Sangeeta N.
Director · Common Stock · 2026-05-04
Sell318
Schneider Jennifer
Director · Common Stock · 2026-05-01
Disposition796
Garber Alan M
Director · Stock Option (Right to Buy) · 2026-05-01
Grant1.43K

SEC filings

EDGAR filings in VRTX · 4 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.